Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hair loss improved with treatment and successful transplant.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Proper nutrition can help manage PCOS symptoms and improve overall health.

Licorice has many health benefits but should be used carefully due to possible side effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.